Last reviewed · How we verify
ChiNing decoction
ChiNing decoction is a traditional Chinese medicine formulation that enhances immune function and inhibits tumor growth through multi-component herbal synergy.
ChiNing decoction is a traditional Chinese medicine formulation that enhances immune function and inhibits tumor growth through multi-component herbal synergy. Used for Cancer (specific indication type not publicly detailed; Phase 3 trial context suggests solid tumors or hematologic malignancy).
At a glance
| Generic name | ChiNing decoction |
|---|---|
| Also known as | Addition and subtraction of Liangge San |
| Sponsor | Tianjin Medical University Cancer Institute and Hospital |
| Drug class | herbal decoction / traditional Chinese medicine |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | Phase 3 |
Mechanism of action
As a decoction (herbal extract), ChiNing combines multiple botanical ingredients traditionally used in Chinese oncology practice. The formulation is believed to work through immunomodulation, promoting anti-tumor immunity, and potentially inhibiting angiogenesis and tumor cell proliferation. The exact molecular mechanisms remain incompletely characterized but likely involve polysaccharides, alkaloids, and other phytochemicals present in the constituent herbs.
Approved indications
- Cancer (specific indication type not publicly detailed; Phase 3 trial context suggests solid tumors or hematologic malignancy)
Common side effects
- Gastrointestinal disturbance
- Allergic reaction
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ChiNing decoction CI brief — competitive landscape report
- ChiNing decoction updates RSS · CI watch RSS
- Tianjin Medical University Cancer Institute and Hospital portfolio CI